Stephen H. Ip, Ph.D.


Independent Director


Stephen H. Ip has over 30 years of experiences in Biotech and Pharmaceutical industry; specializing in senior management position from start up operation to listed public companies, with extensive experiences in business development including successful deals and Joint Ventures with SmithKline Beecham, Yamanouchi, Mitsubishi, P&G Pharmaceuticals, Sysmex, Astra, Chiron, Pfizer, Syntex, Purdue Pharmaceutical, MBL Laboratories, and Bio-Rad Laboratories. He also was the founding member of Cambridge Research Laboratories (Ortho, company of Johnson and Johnson), T Cell Sciences, CytoMed; and the President and Chief Operating Office with American Biogenetic Science, CytoMed, International Bioimmune System and Senior Vice President of Business Development with TaiGen Biotechnology, Matritech, T cell Sciences. Dr. Stephen H. Ip received his Ph.D. (1976) from University of Virginia Medical School, and NIH postdoctoral fellow and Staff at the hematology and oncology department of the University of Pennsylvania Medical School, and was appointed Adj. Associate Professor at Columbia Medical School (Pathology).